首页> 外文OA文献 >PCV74 Cost-Effectiveness Analysis Among Patients With Diabetes Mellitus or Cardiovascular Disease Receiving Second-Line Treatment With Intensive Doses of Simvastatin Atorvastatin and Atorvastatin-Ezetimibe Combination In General Practice

【2h】

PCV74 Cost-Effectiveness Analysis Among Patients With Diabetes Mellitus or Cardiovascular Disease Receiving Second-Line Treatment With Intensive Doses of Simvastatin Atorvastatin and Atorvastatin-Ezetimibe Combination In General Practice

机译：接受辛伐他汀阿托伐他汀加阿托伐他汀-依泽替米贝联合强化治疗二线治疗的糖尿病或心血管疾病患者接受二线治疗的PCV74成本-效果分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Tewthanom K.; Rattanakunooprakarn H.; Sakthong P.;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins [J] . Giorgia De Berardis, Michele Sacco, Virgilio Evangelista, Trials . 2007,第1期

机译：阿司匹林和辛伐他汀联合用于糖尿病的心血管事件预防试验（ACCEPT-D）：一项低剂量阿司匹林在他汀类药物治疗的糖尿病患者中预防心血管事件功效的随机研究设计
2. Effective prevention of cardiovascular disease and diabetes-related events with atorvastatin in Japanese elderly patients with type2 diabetes mellitus: Adjusting for treatment changes using a marginal structural proportional hazards model and a rank-preserving structural failure time model [J] . ShinozakiT., MatsuyamaY., IimuroS., Geriatrics & gerontology international. . 2012,第Suppla1期

机译：用阿托伐他汀有效预防日本老年2型糖尿病患者的心血管疾病和糖尿病相关事件：使用边际结构比例风险模型和等级保留结构失效时间模型调整治疗变化
3. The effect of excess weight gain with intensive diabetes mellitus treatment on cardiovascular disease risk factors and atherosclerosis in type 1 diabetes mellitus: Results from the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study (DCCT/EDIC) study [J] . PurnellJ.Q., JohnE.HokansonDepartmentofMedicine, ClearyP.A., Circulation: An Official Journal of the American Heart Association . 2013,第2期

机译：重量增益与强化糖尿病患者对心血管疾病危险因素和动脉粥样硬化的影响，糖尿病患者的疾病危险因素和动脉粥样硬化：糖尿病患者的糖尿病控制和并发症研究结果和并发症研究（DCCT / edic）研究
4. An explainable XGBoost–based approach towards assessing the risk of cardiovascular disease in patients with Type 2 Diabetes Mellitus [C] . Maria Athanasiou, Konstantina Sfrintzeri, Konstantia Zarkogianni, IEEE International Conference on Bioinformatics and Bioengineering . 2020

机译：一种可解释的XGBoost基方法，旨在评估2型糖尿病患者心血管疾病风险的方法
5. An analysis of the long-term cost-effectiveness of intensive lifestyle intervention for type 2 diabetes mellitus prevention. [D] . Novak, Suzanne. 2005

机译：强化生活方式干预预防2型糖尿病的长期成本效益分析。
6. Aspirin and Simvastatin Combination for Cardiovascular Events Prevention Trial in Diabetes (ACCEPT-D): design of a randomized study of the efficacy of low-dose aspirin in the prevention of cardiovascular events in subjects with diabetes mellitus treated with statins [O] . Giorgia De Berardis, Michele Sacco, Virgilio Evangelista, 2007

机译：阿司匹林和辛伐他汀联合用于糖尿病的心血管事件预防试验（ACCEPT-D）：一项低剂量阿司匹林在他汀类药物治疗的糖尿病患者中预防心血管事件功效的随机研究设计
7. PCV67 Cost-Effectiveness Analysis Of Simvastatin Atorvastatin And Atorvastatin-Ezetimibe Combination Among Patients With Diabetes Mellitus Or Cardiovascular Disease In General Practice [O] . Rattanakunooprakarn H., Tewthanom K., Sakthong P. 2015

机译：糖尿病或心血管疾病患者中辛伐他汀阿托伐他汀和阿托伐他汀-依泽替米贝联合用药的PCV67成本-效果分析

PCV74 Cost-Effectiveness Analysis Among Patients With Diabetes Mellitus or Cardiovascular Disease Receiving Second-Line Treatment With Intensive Doses of Simvastatin Atorvastatin and Atorvastatin-Ezetimibe Combination In General Practice

著录项

引文网络

相似文献

相关主题

期刊订阅